ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc.

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc. Salt Lake City, UT, June 12, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients, announced the appointments of Messers. Jim Hogan, David Nielsen [...]

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’ – ProLung, Inc.

ProLung Announces New Office Location as Anchor Tenant at 'The Labs at Northgate' – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / June 10, 2019 / ProLung, Inc. ("ProLung" or the "Company"), which is focused on reducing the time to diagnosis for lung cancer patients, announced today it has started construction on a new [...]

ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’ – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc.

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc. ProLung is delighted to be honored as the “Med Tech Company of the Year 2019” by Global Health & Pharma. Our ProLung team views external recognition as further validation of our mission to ‘make a difference in time’ [...]

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc.

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc. Salt Lake City, UT, February 1, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients with its ProLung Test™, yesterday announced the preliminary results of its PL-208 Validation Study [...]

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc.

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc. ProLung, Inc. is honored to be named one of the ‘50 leading companies of the year 2018’ by Silicon Review. Furthermore, our interim CEO, Mr. Jared Bauer, is interviewed in their end of the year special issue where [...]

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc.

ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / December 13, 2018 / ProLung, Inc. (''ProLung'' or the ''Company'') is focused on reducing the time to diagnosis for lung cancer patients. ProLung® conducted its 2018 Annual Meeting of Shareholders (''Meeting'') last week with [...]

ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc.2020-02-17T14:34:39-07:00

ProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc.

ProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / November 21, 2018 / ProLung, Inc. ("ProLung" or the "Company") is focused on reducing the time to diagnosis for lung cancer patients. Today ProLung announced final results from its PL-209 repeatability study. The ProLung Test is [...]

ProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc.2020-02-17T14:34:39-07:00

ProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc.

ProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc. - Consent Solicitation Clearly Failed to Receive the Required Majority - Steven Eror Falsely Claimed Victory for the Third Time SALT LAKE CITY, UT / ACCESSWIRE / October 23, 2018 / ProLung, Inc. ("ProLung" or the "Company") announced today the preliminary results of the consent [...]

ProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc.2020-02-17T14:34:39-07:00

ProLung Announces an Intellectual Property and Regulatory Update – ProLung, Inc.

ProLung Announces an Intellectual Property and Regulatory Update – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / October 11, 2018 / ProLung, Inc. ("ProLung" or the "Company") today released a letter to its shareholders with an important intellectual property and regulatory update. ProLung® is pleased to announce receipt of a new Notice of Allowance [...]

ProLung Announces an Intellectual Property and Regulatory Update – ProLung, Inc.2020-02-17T14:34:39-07:00

Former ProLung Directors Support The Company’s Interim CEO Jared Bauer And Incumbent Board Of Directors – ProLung, Inc.

Former ProLung Directors Support The Company's Interim CEO Jared Bauer And Incumbent Board Of Directors – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / October 2, 2018 / ProLung, Inc. ("ProLung" or the "Company") today disclosed a letter to its stockholders from former ProLung® Board Members Clark Campbell, William Fresh, Rich McKeown, Tim Treu [...]

Former ProLung Directors Support The Company’s Interim CEO Jared Bauer And Incumbent Board Of Directors – ProLung, Inc.2020-02-17T14:34:39-07:00